{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:24:07Z","timestamp":1760055847638,"version":"build-2065373602"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"The National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82327806"],"award-info":[{"award-number":["82327806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"The Institute of Artificial Intelligence, Hefei Comprehensive National Science Center","award":["21KT013"],"award-info":[{"award-number":["21KT013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11060-025-05229-0","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:53:20Z","timestamp":1759172000000},"page":"1235-1246","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of temporal muscle thickness in pediatric medulloblastoma patients aged 3\u201312 years"],"prefix":"10.1007","volume":"175","author":[{"given":"Xu","family":"An","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingzhe","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaozhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingnan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunwei","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"5229_CR1","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","volume":"5","author":"PA Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A, Pfister SM (2019) Medulloblastoma. Nat Rev Dis Primers 5:11. https:\/\/doi.org\/10.1038\/s41572-019-0063-6","journal-title":"Nat Rev Dis Primers"},{"key":"5229_CR2","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","volume":"131","author":"DN Louis","year":"2016","unstructured":"Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 world health organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803\u2013820. https:\/\/doi.org\/10.1007\/s00401-016-1545-1","journal-title":"Acta Neuropathol"},{"key":"5229_CR3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G, Boscia A, Kruchko C, Barnholtz-Sloan JS (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united States in 2011\u20132015. Neuro Oncol 20:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro Oncol"},{"key":"5229_CR4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/(sici)1097-0215(19990301)80:5<689::aid-ijc10>3.0.co;2-g","volume":"80","author":"MTSP Giordana","year":"1999","unstructured":"Giordana MTSP, Lanotte M, Girardi P, Chio A (1999) Epidemiology of adult Medulloblastoma. Int J Cancer 80:689\u2013692.","journal-title":"Int J Cancer"},{"key":"5229_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semradonc.2009.09.005","volume":"20","author":"TE Merchant","year":"2010","unstructured":"Merchant TE, Pollack IF, Loeffler JS (2010) Brain tumors across the age spectrum: biology, therapy, and late effects. Semin Radiat Oncol 20:58\u201366. https:\/\/doi.org\/10.1016\/j.semradonc.2009.09.005","journal-title":"Semin Radiat Oncol"},{"key":"5229_CR6","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1177\/0883073808321768","volume":"23","author":"F Nejat","year":"2008","unstructured":"Nejat F, El Khashab M, Rutka JT (2008) Initial management of childhood brain tumors: neurosurgical considerations. J Child Neurol 23:1136\u20131148. https:\/\/doi.org\/10.1177\/0883073808321768","journal-title":"J Child Neurol"},{"key":"5229_CR7","doi-asserted-by":"publisher","first-page":"827054","DOI":"10.3389\/fonc.2022.827054","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, Xiao B, Li S, Liu J (2022) Risk factors for survival in patients with medulloblastoma: A systematic review and Meta-Analysis. Front Oncol 12:827054. https:\/\/doi.org\/10.3389\/fonc.2022.827054","journal-title":"Front Oncol"},{"key":"5229_CR8","doi-asserted-by":"publisher","first-page":"7613","DOI":"10.1158\/1078-0432.CCR-04-0499","volume":"10","author":"AHM Ray","year":"2004","unstructured":"Ray AHM, Ma J et al (2004) A clinicobiological model predicting survival in Medulloblastoma. Clin Cancer Res 10:7613\u20137620. https:\/\/doi.org\/10.1158\/1078-0432.CCR-04-0499","journal-title":"Clin Cancer Res"},{"key":"5229_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00431-020-03722-4","volume":"180","author":"P Sedano","year":"2021","unstructured":"Sedano P, Segundo CG, De Ingunza L, Cuesta-Alvaro P, Perez-Somarriba M, Diaz-Gutierrez F, Colino CG, Lassaletta A (2021) Real-world data for pediatric medulloblastoma: can we improve outcomes? Eur J Pediatr 180:127\u2013136. https:\/\/doi.org\/10.1007\/s00431-020-03722-4","journal-title":"Eur J Pediatr"},{"key":"5229_CR10","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1148\/93.6.1351","volume":"93","author":"CHHE Chang","year":"1969","unstructured":"Chang CHHE, Herbert C Jr (1969) An operative staging system and a megavoltage radiotherapeutic technic for cerebellar Medulloblastomas. Radiology 93:1351\u20131359. https:\/\/doi.org\/10.1148\/93.6.1351","journal-title":"Radiology"},{"key":"5229_CR11","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S1470-2045(06)70867-1","volume":"7","author":"ACM Gajjar","year":"2006","unstructured":"Gajjar ACM, Ashley D et al (2006) Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed Medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol 7:813\u2013820. https:\/\/doi.org\/10.1016\/S1470-2045(06)70867-1","journal-title":"Lancet Oncol"},{"key":"5229_CR12","doi-asserted-by":"publisher","first-page":"4202","DOI":"10.1200\/JCO.2006.06.4980","volume":"24","author":"RJGA Packer","year":"2006","unstructured":"Packer RJGA, Vezina G et al (2006) Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk Medulloblastoma. J Clin Oncol 24:4202\u20134208. https:\/\/doi.org\/10.1200\/JCO.2006.06.4980","journal-title":"J Clin Oncol"},{"key":"5229_CR13","doi-asserted-by":"publisher","first-page":"4726","DOI":"10.1200\/JCO.2005.00.760","volume":"23","author":"V Oyharcabal-Bourden","year":"2005","unstructured":"Oyharcabal-Bourden V, Kalifa C, Gentet JC, Frappaz D, Edan C, Chastagner P, Sariban E, Pagnier A, Babin A, Pichon F, Neuenschwander S, Vinchon M, Bours D, Mosseri V, Le Gales C, Ruchoux M, Carrie C, Doz F (2005) Standard-risk Medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French society of pediatric oncology study. J Clin Oncol 23:4726\u20134734. https:\/\/doi.org\/10.1200\/JCO.2005.00.760","journal-title":"J Clin Oncol"},{"key":"5229_CR14","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1200\/JCO.2011.40.2792","volume":"30","author":"RI Jakacki","year":"2012","unstructured":"Jakacki RI, Burger PC, Zhou T, Holmes EJ, Kocak M, Onar A, Goldwein J, Mehta M, Packer RJ, Tarbell N, Fitz C, Vezina G, Hilden J, Pollack IF (2012) Outcome of children with metastatic Medulloblastoma treated with carboplatin during craniospinal radiotherapy: a children\u2019s oncology group phase I\/II study. J Clin Oncol 30:2648\u20132653. https:\/\/doi.org\/10.1200\/JCO.2011.40.2792","journal-title":"J Clin Oncol"},{"key":"5229_CR15","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1200\/jco.2012.48.5052","volume":"31","author":"N Zhukova","year":"2013","unstructured":"Zhukova N, Ramaswamy V, Remke M, Pfaff E, Shih DJH, Martin DC, Castelo-Branco P, Baskin B, Ray PN, Bouffet E, von Bueren AO, Jones DTW, Northcott PA, Kool M, Sturm D, Pugh TJ, Pomeroy SL, Cho Y-J, Pietsch T, Gessi M, Rutkowski S, Bognar L, Klekner A, Cho B-K, Kim S-K, Wang K-C, Eberhart CG, Fevre-Montange M, Fouladi M, French PJ, Kros M, Grajkowska WA, Gupta N, Weiss WA, Hauser P, Jabado N, Jouvet A, Jung S, Kumabe T, Lach B, Leonard JR, Rubin JB, Liau LM, Massimi L, Pollack IF, Shin Ra Y, Van Meir EG, Zitterbart K, Sch\u00fcller U, Hill RM, Lindsey JC, Schwalbe EC, Bailey S, Ellison DW, Hawkins C, Malkin D, Clifford SC, Korshunov A, Pfister S, Taylor MD, Tabori U (2013) Subgroup-Specific prognostic implications of TP53 mutation in Medulloblastoma. J Clin Oncol 31:2927\u20132935. https:\/\/doi.org\/10.1200\/jco.2012.48.5052","journal-title":"J Clin Oncol"},{"key":"5229_CR16","doi-asserted-by":"publisher","first-page":"23282","DOI":"10.1038\/s41598-021-02651-y","volume":"11","author":"KH Liang","year":"2021","unstructured":"Liang KH, Chang CC, Wu KS, Yu AL, Sung SY, Lee YY, Liang ML, Chen HH, Fen JJ, Chao ME, Liao YT, Wong TT (2021) Notch signaling and natural killer cell infiltration in tumor tissues underlie Medulloblastoma prognosis. Sci Rep 11:23282. https:\/\/doi.org\/10.1038\/s41598-021-02651-y","journal-title":"Sci Rep"},{"key":"5229_CR17","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1111\/j.1750-3639.2012.00631.x","volume":"23","author":"D Aref","year":"2013","unstructured":"Aref D, Moffatt CJ, Agnihotri S, Ramaswamy V, Dubuc AM, Northcott PA, Taylor MD, Perry A, Olson JM, Eberhart CG, Croul SE (2013) Canonical TGF-beta pathway activity is a predictor of SHH-driven Medulloblastoma survival and delineates putative precursors in cerebellar development. Brain Pathol 23:178\u2013191. https:\/\/doi.org\/10.1111\/j.1750-3639.2012.00631.x","journal-title":"Brain Pathol"},{"key":"5229_CR18","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-016-1569-6","volume":"131","author":"V Ramaswamy","year":"2016","unstructured":"Ramaswamy V, Remke M, Bouffet E, Bailey S, Clifford SC, Doz F, Kool M, Dufour C, Vassal G, Milde T, Witt O, von Hoff K, Pietsch T, Northcott PA, Gajjar A, Robinson GW, Padovani L, Andre N, Massimino M, Pizer B, Packer R, Rutkowski S, Pfister SM, Taylor MD, Pomeroy SL (2016) Risk stratification of childhood Medulloblastoma in the molecular era: the current consensus. Acta Neuropathol 131:821\u2013831. https:\/\/doi.org\/10.1007\/s00401-016-1569-6","journal-title":"Acta Neuropathol"},{"key":"5229_CR19","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1200\/JCO.2010.28.1675","volume":"29","author":"P Tamayo","year":"2011","unstructured":"Tamayo P, Cho YJ, Tsherniak A, Greulich H, Ambrogio L, Schouten-van Meeteren N, Zhou T, Buxton A, Kool M, Meyerson M, Pomeroy SL, Mesirov JP (2011) Predicting relapse in patients with Medulloblastoma by integrating evidence from clinical and genomic features. J Clin Oncol 29:1415\u20131423. https:\/\/doi.org\/10.1200\/JCO.2010.28.1675","journal-title":"J Clin Oncol"},{"key":"5229_CR20","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41430-021-01016-y","volume":"76","author":"S Triarico","year":"2022","unstructured":"Triarico S, Rinninella E, Mele MC, Cintoni M, Attina G, Ruggiero A (2022) Prognostic impact of sarcopenia in children with cancer: a focus on the Psoas muscle area (PMA) imaging in the clinical practice. Eur J Clin Nutr 76:783\u2013788. https:\/\/doi.org\/10.1038\/s41430-021-01016-y","journal-title":"Eur J Clin Nutr"},{"key":"5229_CR21","doi-asserted-by":"publisher","first-page":"112077","DOI":"10.1016\/j.nut.2023.112077","volume":"112","author":"YW Yang","year":"2023","unstructured":"Yang YW, Ming Y, Zhou YW, Xia X, Jia SL, Zhao YL, Zhou LX, Cao Y, Ge ML (2023) Prognostic value of Temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis. Nutrition 112:112077. https:\/\/doi.org\/10.1016\/j.nut.2023.112077","journal-title":"Nutrition"},{"key":"5229_CR22","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1093\/neuonc\/noz131","volume":"21","author":"J Furtner","year":"2019","unstructured":"Furtner J, Genbrugge E, Gorlia T, Bendszus M, Nowosielski M, Golfinopoulos V, Weller M, van den Bent MJ, Wick W, Preusser M (2019) Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial. Neuro Oncol 21:1587\u20131594. https:\/\/doi.org\/10.1093\/neuonc\/noz131","journal-title":"Neuro Oncol"},{"doi-asserted-by":"publisher","unstructured":"Furtner J, Nenning KH, Roetzer T, Gesperger J, Seebrecht L, Weber M, Grams A, Leber SL, Marhold F, Sherif C, Trenkler J, Kiesel B, Widhalm G, Asenbaum U, Woitek R, Berghoff AS, Prayer D, Langs G, Preusser M, Wohrer A (2021) Evaluation of the Temporal muscle thickness as an independent prognostic biomarker in patients with primary central nervous system lymphoma. Cancers (Basel) 13. https:\/\/doi.org\/10.3390\/cancers13030566","key":"5229_CR23","DOI":"10.3390\/cancers13030566"},{"doi-asserted-by":"publisher","unstructured":"Cho A, Hennenberg J, Untersteiner H, Hirschmann D, Gatterbauer B, Zochbauer-Muller S, Hochmair MJ, Preusser M, Rossler K, Dorfer C, Frischer JM, Furtner J (2022) Influence of Temporal muscle thickness on the outcome of radiosurgically treated patients with brain metastases from non-small cell lung cancer. J Neurosurg 1\u20137. https:\/\/doi.org\/10.3171\/2021.12.JNS212193","key":"5229_CR24","DOI":"10.3171\/2021.12.JNS212193"},{"key":"5229_CR25","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11060-018-2948-8","volume":"140","author":"J Furtner","year":"2018","unstructured":"Furtner J, Berghoff AS, Schopf V, Reumann R, Pascher B, Woitek R, Asenbaum U, Pelster S, Leitner J, Widhalm G, Gatterbauer B, Dieckmann K, Holler C, Prayer D, Preusser M (2018) Temporal muscle thickness is an independent prognostic marker in melanoma patients with newly diagnosed brain metastases. J Neurooncol 140:173\u2013178. https:\/\/doi.org\/10.1007\/s11060-018-2948-8","journal-title":"J Neurooncol"},{"key":"5229_CR26","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/neuonc\/nor025","volume":"13","author":"AO von Bueren","year":"2011","unstructured":"von Bueren AO, von Hoff K, Pietsch T, Gerber NU, Warmuth-Metz M, Deinlein F, Zwiener I, Faldum A, Fleischhack G, Benesch M, Krauss J, Kuehl J, Kortmann RD, Rutkowski S (2011) Treatment of young children with localized Medulloblastoma by chemotherapy alone: results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology. Neuro Oncol 13:669\u2013679. https:\/\/doi.org\/10.1093\/neuonc\/nor025","journal-title":"Neuro Oncol"},{"key":"5229_CR27","doi-asserted-by":"publisher","first-page":"4151","DOI":"10.1200\/JCO.2016.67.2428","volume":"34","author":"AO von Bueren","year":"2016","unstructured":"von Bueren AO, Kortmann RD, von Hoff K, Friedrich C, Mynarek M, Muller K, Goschzik T, Zur Muhlen A, Gerber N, Warmuth-Metz M, Soerensen N, Deinlein F, Benesch M, Zwiener I, Kwiecien R, Faldum A, Bode U, Fleischhack G, Hovestadt V, Kool M, Jones D, Northcott P, Kuehl J, Pfister S, Pietsch T, Rutkowski S (2016) Treatment of children and adolescents with metastatic Medulloblastoma and prognostic relevance of clinical and biologic parameters. J Clin Oncol 34:4151\u20134160. https:\/\/doi.org\/10.1200\/JCO.2016.67.2428","journal-title":"J Clin Oncol"},{"key":"5229_CR28","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1007\/s00330-016-4707-6","volume":"27","author":"J Furtner","year":"2017","unstructured":"Furtner J, Berghoff AS, Albtoush OM, Woitek R, Asenbaum U, Prayer D, Widhalm G, Gatterbauer B, Dieckmann K, Birner P, Aretin B, Bartsch R, Zielinski CC, Schopf V, Preusser M (2017) Survival prediction using Temporal muscle thickness measurements on cranial magnetic resonance images in patients with newly diagnosed brain metastases. Eur Radiol 27:3167\u20133173. https:\/\/doi.org\/10.1007\/s00330-016-4707-6","journal-title":"Eur Radiol"},{"key":"5229_CR29","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s11547-022-01524-2","volume":"127","author":"F Pasqualetti","year":"2022","unstructured":"Pasqualetti F, Gabelloni M, Gonnelli A, Faggioni L, Cantarella M, Montrone S, Gadducci G, Giannini N, Montemurro N, Mattioni R, Perrini P, Morganti R, Cosottini M, Neri E, Paiar F (2022) Impact of temporalis muscle thickness in elderly patients with newly diagnosed glioblastoma treated with radio or radio-chemotherapy. Radiol Med 127:919\u2013924. https:\/\/doi.org\/10.1007\/s11547-022-01524-2","journal-title":"Radiol Med"},{"key":"5229_CR30","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00330-020-07471-8","volume":"31","author":"R Muglia","year":"2021","unstructured":"Muglia R, Simonelli M, Pessina F, Morenghi E, Navarria P, Persico P, Lorenzi E, Dipasquale A, Grimaldi M, Scorsetti M, Santoro A, Politi LS (2021) Prognostic relevance of Temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis. Eur Radiol 31:4079\u20134086. https:\/\/doi.org\/10.1007\/s00330-020-07471-8","journal-title":"Eur Radiol"},{"key":"5229_CR31","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1080\/01635581.2020.1839519","volume":"73","author":"JV Barreira","year":"2021","unstructured":"Barreira JV (2021) The role of nutrition in cancer patients. Nutr Cancer 73:2849\u20132850. https:\/\/doi.org\/10.1080\/01635581.2020.1839519","journal-title":"Nutr Cancer"},{"key":"5229_CR32","doi-asserted-by":"publisher","first-page":"e28862","DOI":"10.1002\/pbc.28862","volume":"68","author":"A Ritz","year":"2021","unstructured":"Ritz A, Kolorz J, Hubertus J, Ley-Zaporozhan J, von Schweinitz D, Koletzko S, Haberle B, Schmid I, Kappler R, Berger M, Lurz E (2021) Sarcopenia is a prognostic outcome marker in children with high-risk hepatoblastoma. Pediatr Blood Cancer 68:e28862. https:\/\/doi.org\/10.1002\/pbc.28862","journal-title":"Pediatr Blood Cancer"},{"key":"5229_CR33","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s12185-017-2388-9","volume":"107","author":"D Suzuki","year":"2018","unstructured":"Suzuki D, Kobayashi R, Sano H, Hori D, Kobayashi K (2018) Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance. Int J Hematol 107:486\u2013489. https:\/\/doi.org\/10.1007\/s12185-017-2388-9","journal-title":"Int J Hematol"},{"key":"5229_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jss.2018.10.048","volume":"236","author":"N Kawakubo","year":"2019","unstructured":"Kawakubo N, Kinoshita Y, Souzaki R, Koga Y, Oba U, Ohga S, Taguchi T (2019) The influence of sarcopenia on High-Risk neuroblastoma. J Surg Res 236:101\u2013105. https:\/\/doi.org\/10.1016\/j.jss.2018.10.048","journal-title":"J Surg Res"},{"key":"5229_CR35","doi-asserted-by":"publisher","first-page":"e223","DOI":"10.1111\/ajco.13369","volume":"16","author":"H Yesil Cinkir","year":"2020","unstructured":"Yesil Cinkir H, Colakoglu Er H (2020) Is Temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme? Asia Pac J Clin Oncol 16:e223\u2013e227. https:\/\/doi.org\/10.1111\/ajco.13369","journal-title":"Asia Pac J Clin Oncol"},{"key":"5229_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41416-021-01590-9","volume":"126","author":"EMR Mi","year":"2022","unstructured":"Mi EMR, Pakzad-Shahabi L, Chen J, Ho A, Williams M (2022) Deep learning-based quantification of temporalis muscle has prognostic value in patients with glioblastoma. Br J Cancer 126:196\u2013203. https:\/\/doi.org\/10.1038\/s41416-021-01590-9","journal-title":"Br J Cancer"},{"key":"5229_CR37","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1007\/s10143-022-01892-3","volume":"45","author":"N Sadhwani","year":"2022","unstructured":"Sadhwani N, Aggarwal A, Mishra A, Garg K (2022) Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis. Neurosurg Rev 45:3619\u20133628. https:\/\/doi.org\/10.1007\/s10143-022-01892-3","journal-title":"Neurosurg Rev"},{"key":"5229_CR38","doi-asserted-by":"publisher","first-page":"6863","DOI":"10.1038\/s41467-023-42501-1","volume":"14","author":"A Zapaishchykova","year":"2023","unstructured":"Zapaishchykova A, Liu KX, Saraf A, Ye Z, Catalano PJ, Benitez V, Ravipati Y, Jain A, Huang J, Hayat H, Likitlersuang J, Vajapeyam S, Chopra RB, Familiar AM, Nabavidazeh A, Mak RH, Resnick AC, Mueller S, Cooney TM, Haas-Kogan DA, Poussaint TY, Aerts H, Kann BH (2023) Automated temporalis muscle quantification and growth charts for children through adulthood. Nat Commun 14:6863. https:\/\/doi.org\/10.1038\/s41467-023-42501-1","journal-title":"Nat Commun"},{"doi-asserted-by":"publisher","unstructured":"Ritz A, Lurz E, Berger M (2022) Sarcopenia in children with solid organ tumors: an instrumental era. Cells 11. https:\/\/doi.org\/10.3390\/cells11081278","key":"5229_CR39","DOI":"10.3390\/cells11081278"},{"key":"5229_CR40","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.critrevonc.2011.12.003","volume":"83","author":"A Brinksma","year":"2012","unstructured":"Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W (2012) Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol 83:249\u2013275. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.12.003","journal-title":"Crit Rev Oncol Hematol"},{"key":"5229_CR41","doi-asserted-by":"publisher","first-page":"4405","DOI":"10.2217\/fon-2021-0681","volume":"17","author":"DCAM Guven","year":"2021","unstructured":"Guven DCAM, Cakir IY, Kilickap S, Kertmen N (2021) The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme. Future Oncol 17:4405\u20134413. https:\/\/doi.org\/10.2217\/fon-2021-0681","journal-title":"Future Oncol"},{"doi-asserted-by":"publisher","unstructured":"Barr RD, Stevens MCG (2020) The influence of nutrition on clinical outcomes in children with cancer. Pediatr Blood Cancer 67 Suppl 3e28117. https:\/\/doi.org\/10.1002\/pbc.28117","key":"5229_CR42","DOI":"10.1002\/pbc.28117"},{"key":"5229_CR43","doi-asserted-by":"publisher","first-page":"13045","DOI":"10.1038\/s41598-022-17465-9","volume":"12","author":"GA Bateman","year":"2022","unstructured":"Bateman GA, Bateman AR, Subramanian GM (2022) Dilatation of the bridging cerebral cortical veins in childhood hydrocephalus suggests a malfunction of venous impedance pumping. Sci Rep 12:13045. https:\/\/doi.org\/10.1038\/s41598-022-17465-9","journal-title":"Sci Rep"},{"key":"5229_CR44","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.devcel.2020.06.018","volume":"54","author":"F Li","year":"2020","unstructured":"Li F, Simon MC (2020) Cancer cells don\u2019t live alone: metabolic communication within tumor microenvironments. Dev Cell 54:183\u2013195. https:\/\/doi.org\/10.1016\/j.devcel.2020.06.018","journal-title":"Dev Cell"},{"key":"5229_CR45","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JMBS Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JMBS, Stemmler B, L\u00f3pez-Soriano FJ (2014) Cancer cachexia: Understanding the molecular basis. Nat Rev Cancer 14:754\u2013762. https:\/\/doi.org\/10.1038\/nrc3829","journal-title":"Nat Rev Cancer"},{"key":"5229_CR46","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nrc3410","volume":"12","author":"PA Northcott","year":"2012","unstructured":"Northcott PA, Jones DTW, Kool M, Robinson GW, Gilbertson RJ, Cho Y-J, Pomeroy SL, Korshunov A, Lichter P, Taylor MD, Pfister SM (2012) Medulloblastomics: the end of the beginning. Nat Rev Cancer 12:818\u2013834. https:\/\/doi.org\/10.1038\/nrc3410","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05229-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05229-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T07:12:04Z","timestamp":1759993924000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05229-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":46,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["5229"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05229-0","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"29 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Beijing Tiantan Hospital, Capital Medical University (Date May 17, 2022\/No. KY2022\u2014067\u201401). The Ethical Review Committee of Tsinghua University Yuquan Hospital approved the study design of the external test cohorts (Date March 7, 2023\/ No. 2023029).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients or legal guardians provided written informed consent to participate in this study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"All patients or legal guardians provided written informed consent to publish their data.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}